Login / Signup

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.

Giacomo ColtroEmanuela Sant'AntonioGiuseppe A PalumboFrancesco MannelliValerio De StefanoMarco RuggeriElena Maria ElliRoberta ZanottiOscar BorsaniIrene BertozziAndrea DuminucoSilvia BettiGiuseppe CarliFabrizio CavalcaIlaria TanasiElisa RumiMaria L RandiBruno GaribaldiGiuseppe Gaetano LoscoccoPaola GuglielmelliAlessandro M Vannucchi
Published in: Cancer medicine (2023)
Overall, our findings provide insights on the efficacy and safety of ruxolitinib in a real-world, multicenter cohort of Italian MF patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • clinical trial
  • randomized controlled trial
  • quality improvement
  • open label